Living with a narrowed heart valve, known as aortic stenosis, can be a ticking clock. For many patients, the main concern is when the condition becomes dangerous enough to require immediate action. New data helps clarify the timing of these critical decisions.
Researchers looked at 3,086 patients with severe aortic stenosis who did not yet show symptoms. They compared those who received early valve surgery (AVR) against those who were monitored closely by doctors instead. The results showed that those who received the earlier surgery had a significant reduction in major adverse cardiac events (MACE).
MACE is a broad term for serious heart problems like heart attacks or other major complications. While this study shows a clear benefit for early intervention, it is important to remember that MACE is a combined category of different issues. Because the data comes from both clinical trials and observational studies, patients should talk to their doctors to decide the best timing for their specific needs.
